Cheetah Medical, an Israel-based developer of medical devices sold in the US, has raised $14.5m in its series C round from a consortium including Ascension Health and Germany-based industrial group Robert Bosch’s corporate venturing units.
Alongside Robert Bosch Venture Capital (RBVC) and Ascension Health Ventures (AHV) in the round were venture capital firms Springfield Investments and MVM Life Science Partners.
In March 2010, Cheetah raised $20m in its B round from AHV,
RBVC, MVM and others. Walter Lin, an investment manager with AHV and Gadi Toren, venture capital investment partner with RBVC, joined Cheetah’s board at that time.
Founded in 2000, Cheetah has also appointed Chris Hutchison as its executive president and William Denman, as chief medical officer.